Related by context. All words. (Click for frequent words.) 75 susceptibility genes 72 susceptibility locus 70 PTPN# 70 chromosome #p#.# 70 chromosome #q# [001] 70 genetic loci 70 LRRK2 gene 70 genetic polymorphisms 70 MSH2 70 susceptibility loci 69 SLC#A# [002] 69 gene locus 69 MECP2 gene 69 #q#.# [001] 69 TCF#L# gene 69 #q# [001] 69 chromosome #p# [001] 69 KIAA# 69 genetic variants associated 69 BARD1 69 chemokine receptor 68 causative genes 68 causal variants 68 alpha synuclein gene 68 prognostic marker 68 germline mutations 68 PALB2 68 MYH9 gene 68 ADAM# 68 transgenic mouse model 68 APOE4 68 rs# [002] 68 MTHFR 68 TGFBR1 * 6A 68 TCF#L# 68 Hutchinson Gilford progeria 68 microdeletions 68 FGFR2 68 #q# [002] 68 ApoE gene 67 CALHM1 67 FTLD 67 SNP rs# [001] 67 APOE e4 67 PTEN mutations 67 CDH1 67 APOL1 67 #p# [001] 67 diagnostic biomarker 67 hypermethylation 67 apolipoprotein E gene 67 tumor suppressor gene 67 miRNA genes 67 CNTNAP2 67 DLX5 67 tumor suppressor protein 67 progressive neurodegenerative disorder 67 G#S [002] 67 cell adhesion molecule 67 COX2 66 monogenic 66 HLA DRB1 66 hypermethylated 66 LIS1 66 ADPKD 66 autoantigen 66 microcephalin 66 KRAS oncogene 66 VHL gene 66 Janus kinase 66 GPC5 66 MIF protein 66 inherited mutations 66 chromosomal rearrangement 66 C#Y 66 IL#R 66 ataxias 66 IDH1 66 K ras mutations 66 chromosome #q#.# [001] 66 hereditary hemochromatosis 66 gene variants 66 chromosome #q# [002] 66 causative gene 66 CDKN2A 66 IRAK1 66 FLT3 66 missense mutations 66 DQB1 * 66 MAPK pathway 66 genetic polymorphism 66 TP# mutation 66 GBA mutations 66 LKB1 65 polymorphisms 65 sporadic ALS 65 GSTP1 65 Wwox 65 #p#.# [001] 65 hereditary predisposition 65 gene polymorphisms 65 ABCB1 65 KIF6 gene 65 PICALM 65 serine protease 65 ApoE 65 STAT4 65 inherited predisposition 65 huntingtin gene 65 virulence genes 65 Genetic variants 65 chromosomal aberrations 65 CYP#D# gene 65 Hashimoto thyroiditis 65 apolipoprotein E 65 LRAT 65 modifier genes 65 KLF4 65 IGFBP2 65 APOE gene 65 breast cancer metastasis 65 somatic mutations 65 ZNF# 65 MTHFR gene 65 #p# [003] 65 gene APOE4 65 serotonin receptor 65 clusterin 65 aneuploidies 65 rs# [001] 65 genetic variant 65 chromosomal regions 64 microdeletion 64 prognostic markers 64 proto oncogene 64 p# mutation 64 MEF2A 64 TMEM#B 64 CFTR gene 64 G#S mutation 64 FGFR3 64 mtDNA mutations 64 LRRK2 mutations 64 CHEK2 64 susceptibility alleles 64 oxysterols 64 TTR gene 64 FMR1 gene 64 chromosome #q 64 Six3 64 endophenotypes 64 BRAF mutation 64 SH#B# 64 Apolipoprotein E 64 gene MECP2 64 etiologic 64 SORL1 64 genetic variants 64 PB1 F2 64 LRP5 64 COL#A# 64 SMAD4 64 5 HTTLPR 64 KLF# 64 CDX2 64 PTEN gene 64 caveolin 64 apolipoprotein E APOE 64 protein tyrosine phosphatase 64 FGFR1 64 genes predisposing 64 uPAR 64 Li Fraumeni syndrome 64 de novo mutations 64 androgen receptor AR 64 #q#.# [002] 64 Genetic mutation 64 spinocerebellar ataxia type 64 herpesviruses 64 molecular abnormalities 64 CagA 63 gene APOE 63 NF2 63 HMGA2 63 vimentin 63 sCJD 63 missense mutation 63 NOD2 63 promoter methylation 63 mutant allele 63 autism susceptibility genes 63 TSC1 63 E#F# 63 fronto temporal dementia 63 PARP inhibition 63 selective antagonists 63 Epstein Barr virus EBV 63 TAp# 63 transgenic mouse models 63 MYH9 63 genetic determinants 63 gene amplification 63 SNP rs# [002] 63 autosomal dominant disorder 63 Plasmodium vivax 63 NKX2 63 Clusterin 63 KIBRA 63 narcolepsy cataplexy 63 SORL1 gene 63 SHANK3 63 apoE4 63 obesity insulin resistance 63 PPARg 63 spontaneous mutations 63 homeobox gene 63 LPA gene 63 epithelial tumors 63 genetic mutations 63 A3 adenosine receptor 63 #p#.# [002] 63 DNA methylation patterns 63 epigenetic modification 63 R#W [002] 63 neuropsychiatric diseases 63 ADAMTS# 63 5 hydroxymethylcytosine 63 familial adenomatous polyposis 63 mGluR 63 mutations 63 neuroligins 63 beta1 integrin 63 multi factorial disease 63 rs# [003] 63 chromosomal alterations 63 gene variant 63 familial pancreatic cancer 63 mutated gene 63 dysbindin 63 nicotinic receptor 63 promoter hypermethylation 63 human leukocyte antigen 62 PON1 62 p# mutations 62 basal cell nevus syndrome 62 BRAF gene 62 myeloproliferative disorders 62 micro RNAs 62 APOE 62 HNPCC 62 causative mutations 62 microRNA expression 62 dopamine receptor gene 62 CCR3 62 MLH1 62 C. pneumoniae 62 NKX#.# 62 melatonin receptor 62 genetic locus 62 JAK2 mutation 62 proband 62 amyloid cascade 62 sortilin 62 eotaxin 62 clade B 62 mutated genes 62 autosomal 62 autosomal recessive disease 62 mGluR2 NAM 62 colorectal carcinoma 62 IKZF1 62 Mendelian disorders 62 gene fusions 62 ankyrin repeat 62 VEGF receptor 62 BRCA2 gene 62 Chronic pancreatitis 62 autosomal recessive 62 receptor molecule 62 Prox1 62 paraneoplastic 62 Alpha synuclein 62 GSTT1 62 mosaicism 62 CHD7 62 chromosome abnormality 62 astrocytomas 62 NF1 gene 62 plasma kallikrein 62 Upregulation 62 myeloproliferative neoplasms 62 mutation 62 neuronal dysfunction 62 polymorphism 62 gene polymorphism 62 protein misfolding 62 BRAF V#E 62 alpha synuclein protein 62 rs# [004] 62 MGUS 62 CDK4 62 V#F mutation 62 UGT#B# 62 Mitochondrial dysfunction 62 mitochondrial dysfunction 62 CNTNAP2 gene 62 underlying pathophysiology 62 IgA deficiency 62 SSc 62 genomic alterations 62 HFE gene 62 Dysregulation 62 DRB1 * 62 humanin 62 Genetic variation 62 cyclin E 62 Wnt signaling pathway 62 amyloid peptide 62 LRP6 62 osteopontin 62 N Myc 62 allelic variants 62 Nonalcoholic fatty liver 62 Li Fraumeni 62 epigenetic regulation 62 IRF6 62 ATG#L# 62 WNK1 62 ORMDL3 62 VIPR2 62 myeloproliferative 62 suppressor gene 62 BMP2 62 maternally inherited 62 EZH2 62 ApoE4 62 nonsense mutations 62 single nucleotide polymorphism 62 AKT1 62 V Leiden 62 miR #b [001] 62 TP# gene 62 genetic modifiers 62 mitochondrial disorders 61 metalloprotease 61 chromosome #q#.# [002] 61 pDCs 61 neurodegenerative disorder 61 serine threonine kinase 61 IDH mutations 61 predisposing factor 61 MELAS 61 transmembrane receptor 61 tumor suppressor genes 61 methylenetetrahydrofolate reductase 61 gene mutation 61 HG PIN 61 histone deacetylases 61 Beta thalassemia 61 MLL gene 61 HLA B# 61 HLA DRB1 * 61 LRRK2 mutation 61 IDH2 61 muscular dystrophies 61 SCN5A 61 P#X# 61 mutated BRCA1 61 HER2 neu 61 USP# 61 genomic instability 61 CCR5 delta# 61 PTP1B 61 cyclin dependent kinase inhibitor 61 DRD2 gene 61 presymptomatic 61 NR#A# 61 WT1 61 neuroinflammation 61 HLA DQ2 61 CDK8 61 Notch1 61 MLL2 61 PI3 kinase 61 LMNA 61 CaM kinase II 61 frontotemporal dementia 61 endostatin 61 RUNX3 61 Cathepsin B 61 Kv#.# 61 functional polymorphism 61 CXCL5 61 MYCN amplification 61 #q# deletion 61 mutant genes 61 lymphangiogenesis 61 epigenetic mechanisms 61 VKORC1 61 Sonic Hedgehog 61 TNFAIP3 61 HLA DR 61 genes BRCA 61 myelofibrosis polycythemia vera 61 germline mutation 61 gene mutations 61 tyrosine kinase receptor 61 apoE 61 transmembrane protein 61 gene rearrangements 61 epigenetic changes 61 virulence determinants 61 Brugada Syndrome 61 SNCA 61 selective inhibition 61 essential thrombocythemia 61 synuclein 61 MC1R 61 APOE ε4 61 MMP# 61 Nedd4 61 ALK gene 61 Genetic predisposition 61 STK# gene 61 autoinflammatory 61 GSTM1 61 diabetes mellitus DM 61 airway hyperresponsiveness 61 pathogenic mechanisms 61 biologic pathways 61 familial ALS 61 BRCA1 BRCA2 61 genomic deletions 61 airway remodeling 61 JAK2 gene 61 motor neuron degeneration 61 CCR1 61 tRNA synthetase 61 Meckel Gruber 61 genetic variations 61 PPARγ 61 small molecule activators 61 PAR1 61 neuroligin 61 GNAQ 61 T#I [002] 61 mitochondrial mutations 61 ERBB2 61 GLUT1 61 Notch signaling 61 generalized vitiligo 61 ALK mutations 61 hyperinsulinemia 61 BMPR2 61 aberrant methylation 61 chemopreventive agent 61 epigenetic silencing 61 loci 61 JAK2 enzyme 61 commonly mutated genes 61 splice variant 61 epigenetic markers 61 lung adenocarcinoma 61 breast cancer subtypes 61 Src 61 protein encoded 61 C. neoformans 61 catechol O methyltransferase 61 renal fibrosis 61 ANGPTL4 61 mutated K ras 61 thyroid hormone receptor 61 chromosome #p# [002] 61 perilipin 61 HLA genes 61 microsatellite instability 61 promoter polymorphism 61 genetic aberrations 61 Fatty liver 61 CYP#D# 61 microRNA miR 61 p# gene 61 Helicobacter 61 TRAF1 C5 61 Signaling Pathway 60 BCL#A 60 SLC#A# gene [001] 60 gene loci 60 aneuploidy 60 progranulin gene 60 ERBB4 60 lysosomal storage diseases 60 elevated CRP 60 WDR# 60 CCR2 60 TLR3 60 transient receptor 60 NKG2D 60 SLC#A# [001] 60 distinct subtypes 60 MUC1 * 60 parkinsonism 60 CNVs 60 methylation patterns 60 DLC1 60 APOE genotype 60 ENaC 60 Brd4 60 progressive neurodegenerative 60 apoptotic pathway 60 Stat5 60 AGTR1 60 epigenetic alterations 60 prognostic indicator 60 p# MAPK 60 chitinase 60 genetic abnormalities 60 FGFs 60 nNOS 60 pathological hallmark 60 progranulin protein 60 DNMT1 60 gene BRCA2 60 receptor gene 60 CIB1 60 enteroviruses 60 molecular subtypes 60 parkin gene 60 TNFa 60 sphingolipid 60 dominantly inherited 60 haplotype 60 IDH1 mutation 60 CHRNA5 60 PIK3CA 60 PON1 gene 60 inhibitory receptor 60 splice junctions 60 SCN9A 60 NOTCH1 60 thyrotropin 60 Loeys Dietz syndrome 60 catenin 60 Immunohistochemical analysis 60 gastric carcinogenesis 60 heterozygotes 60 glycogen synthase kinase 60 Entamoeba histolytica 60 familial hypercholesterolemia 60 human papilloma viruses 60 oncogenesis 60 NF1 60 penetrance 60 systemic amyloidosis 60 SOD1 gene 60 activating mutation 60 NRTI resistance 60 molecular pathway 60 PDGF receptor 60 Alu elements 60 neuropathologic 60 FXTAS 60 CFH gene 60 peroxisomal 60 monocyte chemoattractant protein 60 NPM1 60 phosphate S1P 60 K#R [002] 60 autoantibodies 60 PTEN tumor suppressor 60 underlying molecular mechanisms 60 activated microglia 60 abnormal glucose metabolism 60 somatic mutation 60 glutamic acid decarboxylase 60 PKM2 60 IL #R 60 Cx# [001] 60 SNPs 60 nonhereditary 60 ApoE4 gene 60 Chromosome 60 MC4R gene 60 TGF β 60 splice variants 60 Smad3 60 genetic biomarkers 60 receptor protein 60 nephronophthisis 60 β amyloid 60 PDE#A 60 intracellular bacteria 60 p# activation 60 pancreatic endocrine 60 CHD5 60 Factor Receptor 60 p#INK#a 60 etiologic agent 60 protein tyrosine phosphatase 1B 60 IL 7R 60 neurexin 60 evolutionarily conserved 60 alleles 60 regulates gene expression 60 protein kinase C 60 Glioma 60 cyclophilin D 60 precursor lesions 60 NPY gene 60 ALDH2 60 CYP#A# gene 60 Safinamide 60 LRRK2 60 BRAF V#E mutation 60 AMACR 60 Chlamydia pneumoniae 60 Brugada syndrome 60 oncoprotein 60 PI3K pathway 60 etiologic factors 60 noncoding RNAs 60 Htt 60 glucose transporter 60 interferon pathway 60 DRD4 60 E selectin 60 Epstein Barr Virus EBV 60 engineered RAP peptides 60 INF2 60 eNOS 60 Darapladib 60 nestin 60 pharmacologic intervention 60 GPR# [002] 60 cytotoxin 60 UGT#A# * 60 oncogenic 60 CD#L 60 synapse formation 60 EP3 receptor 60 PAOD 60 JAK2 60 micro RNA 60 Dystrophin 60 metabotropic glutamate receptors 60 multiple sclerosis psoriasis 60 protein p# 60 node metastases 60 HDL2 60 CYP#C# [002] 60 FCGR3A 60 #S rRNA 60 eIF 4E 60 Leukemias 60 soluble fms 60 mitogen activated protein kinase 60 endogenous ligands 60 haplotypes 60 autoantibody 60 autoimmune thyroid 60 Alzheimer disease pathogenesis 60 Lyn kinase 60 neurofibromatosis type 60 mRNA transcripts 60 GABA receptor 60 KCNQ1 60 SLITRK1 59 c MYC 59 Treg cell 59 phenotypic variation 59 JAK inhibitors 59 regulator CFTR gene 59 diagnostic biomarkers 59 EGFR mutations 59 JAK STAT 59 pathophysiologic 59 GSK3 59 PKCi 59 cyclin dependent kinase 59 Apobec3 59 nAChR 59 CDH# 59 progranulin 59 genomic rearrangement 59 protein tau 59 Neurofibromatosis type 59 APOE allele 59 cardiac fibrosis 59 MIF gene 59 TET2 59 PITX2 59 multifactorial disease 59 posttranslational modifications 59 STK# [002] 59 kinase gene 59 NEDD9 59 TTR amyloidosis 59 LDL receptor 59 euthymic patients 59 Lymphocytic 59 chronic granulomatous disease 59 lipid abnormalities 59 genomewide 59 autosomal dominant 59 SIRT1 gene 59 medulloblastomas 59 von Hippel Lindau 59 thrombospondin 59 Wnt#b 59 CpG island 59 coinfection 59 Pdx1 59 VNTR 59 HAAH 59 CYP# [002] 59 nasopharyngeal carcinoma 59 lipoxygenase 59 APOC3 59 DGAT1 59 genetic syndromes 59 DRD2 59 genes BRCA1 59 ribosomal protein 59 Protein Kinase C 59 cadherin 59 MeCP2 gene 59 FOXP3 59 IFRD1 59 Ets2 59 Kufs disease 59 PTHrP 59 gene 59 gastric carcinoma 59 Epstein Barr Virus 59 myopathies 59 CAG repeats 59 preclinically 59 apolipoprotein E4 59 melanocyte 59 neuroblastoma tumors 59 TEL AML1 59 microglial cells 59 DISC1 59 HOX genes 59 breast cancer genes BRCA1 59 thyrotropin levels 59 TP# mutations 59 GPx 59 tumor suppressors 59 chromosomal translocations 59 APOA5 59 TOMM# 59 neuropsychiatric disorders 59 constitutively expressed 59 spinocerebellar ataxia 59 PIGF 59 MDM2 59 PTEN protein 59 SHANK3 gene 59 SCD1 59 gastric adenocarcinoma 59 physiologic mechanisms 59 subclinical 59 CFTR cystic fibrosis transmembrane 59 subclinical hyperthyroidism 59 C5aR 59 hepatic lipase 59 arterial calcification 59 uPA 59 drug metabolizing enzymes 59 BRCA2 mutation 59 hypomethylation 59 tyrosine phosphorylation 59 Systemic lupus erythematosus SLE 59 imatinib resistance 59 EphA2 59 chromosomal instability 59 JAK mutations 59 5 HT1A 59 Monocyte 59 HSV1 59 inherited neurological disorder 59 Leydig cell 59 isoenzymes 59 neuropsychiatric disorder 59 Vascular dementia 59 Skp2 59 quantitative trait loci 59 multidrug resistance 59 klotho 59 matriptase 59 GPNMB 59 Polymorphisms 59 OCA2 59 presenilin 59 γ secretase 59 pRb 59 monocytes macrophages 59 histone deacetylase inhibitors 59 arginase 59 SIRT3 59 receptor tyrosine kinase 59 p#NTR 59 orthologs 59 heterozygote 59 Colon polyps 59 Cyclin D1 59 leukocyte adhesion 59 cellular pathways 59 c KIT 59 KCNH2 59 nongenetic 59 GATA3 59 IL#B 59 HOTAIR 59 nicotine receptor 59 esophageal squamous cell carcinoma 59 3'UTR 59 QTL mapping 59 diabetes mellitus T2DM 59 SOD1 59 inhibit metastasis 59 mitochondrial toxicity 59 myeloproliferative neoplasms MPNs 59 tryptophan hydroxylase 59 primary cilia 59 S. maltophilia 59 dopamine D4 receptor 59 Neurodegenerative diseases 59 #F FDG PET 59 idiopathic myelofibrosis 59 synovial cells 59 microchimerism 59 autosomal recessive disorder 59 serotonin transporter 59 vitro assay 59 IKKß 59 thrombophilia 59 demethylation 59 PDGFR 59 Enzastaurin 59 acetylcholine receptor 59 dyskeratosis congenita 59 C#T [002] 59 receptor subtype 59 DHFR 59 p#/CBP 59 NFkB 59 5 lipoxygenase 59 autoantigens 59 TGF beta pathway 59 pathogenetic 59 kallikrein 59 PCA3 gene 59 neuroblastomas 59 Akt3 59 PEDF 59 IGF2 59 cholesteryl ester transfer 59 conserved sequences 59 HER2 receptor 59 Aviptadil 59 genetic abnormality 59 soluble CD# ligand 59 GSTM1 gene 59 amino acid substitution 59 mGluR5 antagonist 59 Klotho gene 59 M. pneumoniae 59 tumor suppressor 59 nanobacteria 59 #beta HSD1 59 nonalcoholic steatohepatitis NASH 59 TSLP 59 TRPV3 59 IGFBP 3 59 squamous cell lung cancer 59 dexpramipexole 59 STAT3 59 miRs 59 Neuregulin 1 59 IRS1 59 CYT# potent vascular disrupting 59 Squamous 59 c myc 59 genetic alteration 59 Galectin 59 immunohistochemical 59 metabolic abnormalities 59 systemic inflammation 59 glycosylated 59 histone methylation 59 Epidermal Growth Factor Receptor 59 signaling cascades 59 genomewide association studies 59 Estrogen Receptor 59 T#M 59 molecular biomarkers 59 ERK signaling 58 FUS1 58 intronic 58 Myostatin 58 transcriptional repression 58 IKK2 58 receptor alpha 58 CHRNA5 gene 58 PTP 1B 58 #HT#A 58 DNA methylation markers 58 GPR# [001] 58 anaplastic lymphoma kinase 58 TG2 58 paraganglioma 58 NFAT 58 transcriptional regulation 58 conductance regulator 58 Brodmann Area 58 proliferator activated receptor 58 cyclin D1 58 SCN1A 58 lymphocytic 58 Fas ligand 58 tau pathology 58 cytokine receptor 58 Brain derived neurotrophic 58 TOP2A 58 leukotriene pathway 58 constitutively active 58 malignant transformation 58 B7 H3 58 CYP#B# 58 LHON 58 SLC#A# gene [002] 58 miR #a [002] 58 muscarinic 58 palmitoylation 58 HbF 58 NR2B 58 C1q 58 estrogen receptor alpha 58 homozygosity 58 palladin 58 Cowden syndrome 58 Id1 58 familial clustering 58 activin 58 T1D 58 CXCR4 receptor 58 malignant lymphoma 58 klotho gene 58 SIRT2 58 NKT cells 58 inactivating mutations 58 Jhdm2a 58 androgen receptor gene 58 metabolic enzymes 58 AAV2 58 FOXO3a 58 receptor antagonists 58 transcriptional repressor 58 bcl 2 58 hepatocellular carcinomas 58 immunodeficiency disorders 58 chromosomal anomalies 58 chemoresistance 58 alternatively spliced 58 ALK inhibitors 58 signaling molecule 58 genes CYP#C# 58 Bardet Biedl syndrome 58 Angiotensin converting enzyme 58 motor neuron diseases 58 Notch receptor 58 dopamine receptor 58 IKK beta 58 Hedgehog signaling 58 phosphorylates 58 transactivation 58 neurodevelopmental disorder 58 ErbB3 58 KRAS mutations 58 PI3K AKT 58 FGF2 58 pathophysiological effects 58 retrovirus XMRV 58 LPA1 58 peroxisome proliferator activated 58 MAOA gene 58 Overexpression 58 autoimmune pancreatitis 58 upregulates 58 TACI 58 pyruvate kinase 58 amyloid beta plaques 58 non coding RNA 58 Lafora disease 58 nonalcoholic fatty liver 58 EML4 ALK 58 TNF blocker therapy